51ºÚÁϳԹÏÍø

ISSN: 2278-0238

International Journal of Research and Development in Pharmacy & Life Sciences
51ºÚÁϳԹÏÍø

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 51ºÚÁϳԹÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

51ºÚÁϳԹÏÍø Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

REVIEW ON PHARMACOLOGICAL ACTIVITIES OF LIGUSTRUM OVALIFOLIUM

Abstract

The identification of privet in the middle southern United States can be difficult. Because most introduced species of privet can be invasive, and recent mapping projects seek location and species population data, proper identification is important. Ligustrum is currently marketed as a treatment for strengthening the immune system, R 3\05\ 9and on this basis is often recommended for use by people undergoing treatment for cancer or HIV. There is no meaningful scientific evidence that ligustrum provides any benefit for these, or any other, conditions. Very weak evidence from test-tube and animal studies hints that ligustrum might have anti-parasitic, 1 anti-viral, 2l iver-protective , 3immunomodulatory (this means “altering” immune function, rather than, as commonly misunderstood, “strengthening” it), 4,5 and cancer-preventive 6 effects. However, this evidence is too preliminary to rely upon at all. Ligustrum ovalifolium are used the activities of hypotensive activity, hypoglycemic activity, anti inflammatory activity and antioxidant activity.

Keywords

International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top